Loading organizations...
Elm Street Ventures operates as a seed and early-stage venture capital fund based in New Haven, Connecticut. The firm focuses its investments on nascent companies, frequently those emerging from cutting-edge research conducted by Yale University faculty. Their approach centers on identifying and supporting high-potential ventures, providing the capital and guidance necessary for their foundational growth and development.
The firm was established in 2006 by Rob Bettigole, who serves as the managing partner. Bettigole, an experienced venture capitalist with a background as an engineer and entrepreneur, founded Elm Street Ventures with the insight that significant investment opportunities resided within the innovative ecosystem surrounding Yale University's research and academic talent.
Elm Street Ventures' portfolio comprises early-stage companies that benefit from the fund's strategic and financial backing. The firm’s vision is to foster the translation of scientific and technological advancements into viable commercial enterprises, cultivating the next generation of innovative businesses and contributing to the broader entrepreneurial landscape.
Key people at Elm Street Ventures.
Elm Street Ventures was founded in 2006 by Rob Bettigole (Founder & Managing Partner).
Elm Street Ventures was founded in 2006 by Rob Bettigole (Founder & Managing Partner).
Key people at Elm Street Ventures.
Elm Street Ventures has 8 tracked investments across 5 companies. The latest tracked deal is $22.0M Series A in CellFE in September 2023.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Sep 1, 2023 | CellFE | $22.0M Series A | Christian Uhrich | Canvas Ventures, Celesta, Cota Capital, Dynamk Capital, Menlo Ventures, EGB Capital, Embark Ventures, GreatPoint Ventures, Khosla Ventures, Riverine Ventures |
| Mar 11, 2021 | Cybrexa Therapeutics | $25.0M Series B | — | Kevin Rakin |
| Mar 1, 2021 | Artizan | $11.0M Series A | Donnie Mcgrath, Hatteras Venture Partners | Connecticut Innovations, Osage University Partners |
| Jan 1, 2020 | P2 Science | $12.0M Series C | CHANEL, KIP Frey | Connecticut Innovations, BASF Venture Capital, Ironwood Capital, Safer Made, Xeraya Capital |
| Jan 1, 2020 | CellFE | $5.0M Seed | Cota Capital, Dynamk Capital | Canvas Ventures, Celesta, Menlo Ventures, Embark Ventures, McEwan Lane Family Trust |
| Apr 1, 2014 | P2 Science | $1.0M Series A | Connecticut Innovations | — |
| Sep 1, 2013 | Arvinas | $15.0M Series A | 5AM Ventures, Canaan Partners | Andreessen Horowitz, Canaan Partners, Connecticut Innovations, Nextech Invest |
| May 1, 2013 | P2 Science | $650K Seed | Connecticut Innovations | — |
